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Responses to Reviewers' comments: 
 
Reviewer #1: Overall I felt the review paper was comprehensive and well written; however, 
there are a few minor concerns that I would like to see addressed. 
 
Q. My first concern is related to the section on eicosanoid synthesis (lines 64-88).  I found this 
section of the paper hard to read, as it did not clearly explain the metabolic pathways. I 
believe the overall description is correct, it is just that some of the initial steps are not defined 
well and create minor confusion. Initially, when the authors describe eicosanoids being 
synthesized from 20 carbon PUFAs, they do not mention which PUFA's are the 20 carbon 
ones. I believe this causes some confusion throughout the section. I think AA and EPA need to 
be introduced a bit more thoroughly to help things flow better and give the reader a tighter 
grasp on the pathways. A lot of fatty acids are mentioned initially as required, and I think 
explaining the 20 carbon fatty acids as precursors more clearly will help. 
 
A. We have now given more clear explanation of the PUFA metabolic pathways and stated the 
importance of AA and EPA in these pathways.  
 
Q. On line 69 the authors mention the 'two' PUFA families. Lines 39/40 talk about the 3 PUFA 
families. Just clarify that it is the n-6 and n-3 pathways which are of concern, not the n-9's.  
 
A. We have now clarified the importance of n-3 and n-6 pathways. 
 
Q. Line 72 mentions the 'rate-limiting steps'. Elaborate on this slightly. 
 
A. The explanation is now added. 
 
Q. Line 73 discusses membrane phospholipids. Perhaps this is a good place to discuss what the 
most common PUFA's are in membrane lipids and tie the 20 carbon fatty acids to the 
pathway more clearly.  
 
A. As to the most common PUFAs in the membrane, this depends on the cell types and stages of 
the development. For example, AA is one of the most common PUFAs in many “activated” 
immune cells and endometrial tissues and placenta can actively transfer the long chain 
PUFAs. This is very complicated and is somewhat out of the scope of this review.  
 
Q. My final concern for the eicosanoid section is line 87. The authors state that AA is the 
preferred substrate for the enzymes being discussed and I would either like a reference 
included here or clarification. My understanding is that with the delta-5 and -6 desaturase 
enzymes, they prefer n-3 fatty acids over n-6 (see Palmquist, 2009). I am unaware of the 
substrate preferences for PTGS enzymes and would like clarification.  
 
A. We understand that it has been reported that delta-5 and -6 desaturase enzymes prefer n-3 
PUFAs. The substrates for PG production (DGLA, AA and EPA) may be provided by both the 
metabolisms by the desaturases and dietary intake.  Therefore the key enzymes which 
determine PG production are PTGS1 and PTGS2. Although the Km values of both PTGS1 and 
PTGS2 are similar between AA and EPA, their Vmax values for the enzyme reaction are much 
different.  The turnover of PGs for EPA is 10% and 35% of those of AA with PTGS1 and PTGS2, 
Response to reviewers and editors
respectively. This was discussed in details previously (Smith WL. Cyclooxygenases, peroxide 
tone and the allure of fish oil. Curr Opin Cell Biol 2005; 17:174-182). We have now added it to 
our references. 
 
Q. I found the rest of the paper to be very clear and well written.  
 
A. Many thanks. 
 
Q. Line 208 - please clarify if the number of animals required to see differences vary between 
mono vs. poly ovulators since both groups of animals are covered in the review.  
 
A. This is a good point. We have now added some actual power calculations to the text for 
polytocous and monotocous species. 
 
Q. Again, the overall paper was very well written, and with revisions to that first section on 
eicosanoid synthesis, I see no reason why it should not be published. I think the authors touched 
on and attempted to seek valid explanations as to the high variability across studies in terms of 
results and touched on relevant issues such as the n-6 to n-3 ratios.  
 
A. Many thanks for your positive comments. We tried our best to address these issues. 
 
 
 
 
Reviewer #2:  
Q. The paper is well written and informative.  Not a lot is published in this area and the 
authors are correct in commenting that there are equivocal results published and difficulties in 
interpreting some papers due to different methodologies and different sources of PUFAs.  
There are some published papers from pig studies that could be included in the review (see 
below).   
 
A. Again, many thanks for your positive comments. We have tried our best to address these 
issues. 
 
Q. P3, L36: suggest changing to "...roles within the mammalian body, including the supply of 
energy; as structural components of membranes; and by acting...". 
 
A. Done. 
 
Q. P3, LN46: suggest changing to "LA and ALA cannot be synthesized by animals as they lack the 
desaturase enzymes capable of inserting a double bond between C9 and the terminal methyl 
group of the acyl chain". 
 
A. Done 
 
Q. P3, LN58: "...to supply energy and become incorporated into..." 
A. Done 
 
Q. P4, LN87:  Some mention of rate of bioconversion from C18 PUFA to C20 and C22 (LCPUFA) 
would be worthwhile.  
 
A. This is covered by the changes made in response to Reviewer 1. 
 
Q. P4, LN92: "...production, again through a variety..." 
 
A. Done 
 
Q. P7, LN 166-167: suggested change "...reduces the production of pro-inflammatory eicosanoids 
(2-series) derived from AA. EPA instead give rise to eicosanoid mediators that are less 
inflammatory (3-series), while both ...." 
 
A. Done 
 
Q. P7, LN190: Suggested change "Ruminant diets usually have a fodder component..." 
 
A. Done 
 
Q. P7, LN192: suggest an inserted sentence: "This can be overcome by the use of protected oils 
as calcium soaps which bypass the rumen and release LCPUFA into the small intestine" (see 
Staples, Burke, Thatcher 1998. J Dairy Science 81:856-871). 
 
A. We have added something similar although this does not remove the problem that the diet 
for cows still has to contain fodder! 
 
Q.  P8, LN210: Other limitations to interpreting outcomes between studies occur due to 
synchronisation protocols using exogenous prostaglandins or progesterone?  See Estienne et al 
2006. 
A. We agree this is another issue but decided it was outwith the scope of this review 
 
Q. P9, LN230: see also paper by Perez-Rigau, A. et al 1995 J Animal Science 73:1372-1380 on 
ovulation response to PUFAs in pigs 
A. This reference is now included (no. 66). 
 
 Q. P9, LN252: "... but evidence to support this is lacking." 
A. Changed 
 
Q. P9, LN259: Is this statement correct? "...almost all animals experience a uterine infection at 
this time...".  I would disagree that it occurs in 'almost all animals' It doesn't often occur in pigs 
after uterine involution.   
 
A.Yes it is correct for cows so changed the word 
 
Q. P12, LN 323: In contrast to the references given, others have found some positive responses to 
embryo survival in pigs.  See reference Perez-Rigau et al 1995 J Animal Science 73:1372-1380 and 
Smits RJ et al 2013, Animal Production Science 53: 57-66. It is also reported omega 3 LCPUFAs 
have positive efects on litter size in pigs (see Palmer WM et al 1970 J Animal Science 31: 535-
539; Smits RJ et al 2011 J Animal Science 89: 2731-2738) P14, LN389:  See also paper by Brazle 
AE et al 2009 J Animal Science 87:994-1002 for PUFA uptake in uterine tissue in pigs P15, LN451: 
For reports in pigs on pregnancy rate/farrowing rate responses see Palmer et al 1970 and Smits 
et al 2011 as per above references)  
 
A. We have added more on embryo survival in pigs to include these references. 
 
Q. P20, LN35: formatting change in references  
 
A. corrected 
 
Q. P30, Figure 1: The use of the abbreviation COX enzymes.  In the text on P4, LN57 the authors 
refer to PTGS1 and PTGS2 to superceed the terms COX 1 and COX 2 cycloxygenases.  The 
terminology needs to be consistent. 
 
A. Changed on figure and legend 
 
1 
 
Polyunsaturated fatty acids and fertility in female mammals – an update 
 
D. Claire Wathes, Zhangrui Cheng, Waleed Marei
a
 and Ali Fouladi-Nashta 
 
Address: Reproduction Group, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, 
Herts, AL9 7TA, UK 
 
a
Present address: Department of Theriogenology, Faculty of Veterinary Medicine, Cairo University, Giza 
12211, Egypt. 
 
Correspondence: Claire Wathes. Email dcwathes@rvc.ac.uk 
 
Manuscript
Click here to download Manuscript: PUFAs and fertility in female mammals-19June_revised.doc 
2 
 
 
Abstract  1 
 2 
Both n-3 and n-6 polyunsaturated fatty acids (PUFAs) are derived from the diet, with concentrations in 3 
the reproductive tract reflecting dietary intake. PUFAs have multiple functions: as precursors to 4 
eicosanoids, regulators of steroid biosynthesis, inflammatory mediators and supplying energy 5 
(particularly in oocytes). The PUFA composition of cell membranes affects signalling pathways and 6 
susceptibility to oxidative damage. All of these roles may influence reproduction although results are 7 
often inconsistent between studies. Supplementation of cows with various PUFAs can increase the 8 
numbers of antral follicles although work on polyovular species (pigs, rodents) has usually failed to detect 9 
a change in ovulation rate. The anti-inflammatory actions of n-3 PUFAs may reduce follicular PGE 10 
production, delaying ovulation and allowing ovulatory follicles to grow larger and produce more steroid. 11 
Various PUFA supplements can reduce the interval from calving until first ovulation in cattle although 12 
the mechanism is uncertain. Both n-3 and n-6 PUFA supplements have been fed to various species before 13 
collecting oocytes for in vitro fertilization. Positive, negative and no effects on subsequent embryo 14 
development have all been reported. When PUFAs are added directly to oocyte maturation medium, high 15 
doses of linoleic acid (18:2 n-6) are consistently deleterious, while α-linolenic acid (18:3n-3) has been 16 
associated with positive outcomes. Uterine prostaglandin production regulates luteal regression and 17 
pregnancy recognition. Supplementary n-3 PUFAs have either increased or decreased PGF2α production 18 
in different studies. There is some evidence that cattle and pigs fed a PUFA supplement post insemination 19 
may have an increased pregnancy rate.  20 
 21 
Keywords: fertility, prostaglandin, steroid, embryo, follicle, endometrium, ovulation 22 
 23 
Review methodology  24 
 25 
CAB Abstracts and PubMed were searched for papers combining the term polyunsaturated (or PUFA) 26 
with keywords relating to female fertility (fertility, ovary, oocyte, follicular fluid, granulosa, ovulation, 27 
fertilization, luteal/corpus luteum, endometrium). Reference lists in recent relevant review articles and 28 
recent articles citing earlier reviews were also scrutinised. The main focus was on papers published since 29 
2007. 30 
 31 
32 
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 33 
Introduction 34 
 35 
Lipids have many important roles within the mammalian body, including the supply of energy, as 36 
structural components of membranes and by acting as signalling molecules. They are obtained from fats 37 
and oils in the diet which are broken down in the stomach and small intestine into fatty acids, cholesterol, 38 
triglycerides and phospholipids. Fatty acids are carboxylic acids with long-chain hydrocarbon side 39 
groups. There are three families of polyunsaturated fatty acids (PUFAs), omega-3 (n-3), omega-6 (n-6) 40 
and omega-9 (n-9). These all have more than one double bond present in the molecule and are classified 41 
into these families on the position of the first double bond relative to the methyl end of the molecule. 42 
Further members of the n-6 family are derived from linoleic acid (18:2 n-6, LA) by a process of 43 
desaturation and elongation, while n-3 family members are derived from α-linolenic acid (18:3n-3, ALA) 44 
(Figure 1). The enzymes involved, ∆6- and ∆5-desaturases and elongases, are most abundant in liver, 45 
where PUFA metabolism principally occurs [1]. LA and ALA themselves cannot be synthesised by  46 
animals, as they lack the desaturase enzymes capable of inserting a double bond between C9 and the 47 
terminal methyl group of the acyl chain [2]. They are, however, essential to life so must be obtained from 48 
the diet. The main sources of LA are vegetable oils, while ALA is present in green leafy vegetables, 49 
marine algae, seeds and nuts (e.g. linseed, walnuts) and the longer chain n-3 PUFAs eicosapentaenoic 50 
acid (EPA) and docosahexaenoic acid (DHA) are found at high concentrations in fish oils. During the 51 
process of digestion, a significant proportion of the dietary PUFAs become saturated, so the amounts 52 
reaching the circulation are less than those initially consumed. This is particularly true in ruminants, 53 
where ingested food is subjected to biohydrogenation by rumen microbes [3]. Nevertheless, the 54 
proportions of different PUFAs found in cell membranes throughout the body do generally reflect the 55 
amounts consumed in the diet [4]. 56 
 57 
Mechanisms of action 58 
 59 
As lipids, PUFAs can be metabolized within the body to supply energy and become incorporated into 60 
cellular components. A tiny proportion of them are metabolised into signalling molecules with important 61 
biological functions.  62 
  63 
Eicosanoid synthesis 64 
 65 
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Eicosanoids are physiologically active compounds derived from 20 carbon PUFAs which include 66 
prostaglandins (PGs), leukotrienes, thromboxanes, lipoxins, neuroprotectins and resolvins [5-8, Figure 1]. 67 
ALA and LA are essential PUFAs which cannot be synthesized in the mammalian body and must be 68 
provided from the diet. After intake, they are incorporated into membrane phospholipid pools and 69 
released by the action of phospholipase A2 or the co-ordinate actions of phospholipase C and diglyceride 70 
lipase [7].  Following sequential desaturation and elongation, ALA is converted to stearidonic acid (SDA, 71 
18:4n-3), eicosatetraenoic acid (20:4n-3) and EPA while LA is catalysed to -linolenic acid (GLA, 18:3n-72 
6), dihomo--linolenic acid (DGLA, 20:3n-6) and AA. The above metabolites can incorporate back into 73 
cellular membrane phospholipids or are subject to further metabolism.  The enzymes PTGS1 and PTGS2 74 
(previously known as cyclooxygenase (COX)-1 and COX-2) catalyse DGLA, AA and EPA into 1-, 2- and 75 
-3 series PGs respectively. The 5-lipoxygenase (LOX) pathway generates 4-series leukotrienes (LTs) 76 
from AA and 5-series LTs from EPA. The 15-LOX and 5-LOX pathways catalyse AA sequentially to 77 
produce 4-series lipoxins (LXs), EPA to 5-series LXs or DHA into another family of lipid mediators, the 78 
neuroprotectins (Figure 1). Both aspirin-dependent and -independent pathways generate E series resolvins 79 
(RvEs) from EPA and D series resolvins (RvDs) from DHA [8]. These are produced in a tissue-specific 80 
manner which depends on the combination of precursor lipids and enzymes present in the cells.  81 
 Much work on the actions of different PUFAs has examined their influence on PG synthesis. 82 
The system is extremely complex. Each PUFA family produces its own specific metabolites and cross-83 
metabolism between the families cannot happen [5]. The n-3 and n-6 PUFA families compete with each 84 
other for both cellular membrane lipid incorporation and metabolic enzymes [6]. This competition can 85 
influence the amounts of different longer chain PUFAs (LCPUFAs) produced from ALA and LA, 86 
although dietary supplementation with longer chain n-3 (SDA, EPA) or n-6 (GLA, AA) PUFAs can by-87 
pass the rate-limiting step. This is the slowest step which determines the speed and efficiency of the 88 
reaction chain.   The studies on supplementation and interactions between n-3 and n-6 PUFA families 89 
have attracted considerable interest as their metabolism leads to different families of PGs and resolvins as 90 
outlined above. Particular attention has been paid to EPA and AA because they are direct precursors for 91 
the production of many eicosanoids and their intracellular concentration can be influenced by both dietary 92 
and in vitro manipulation. The pattern of PUFA-derived mediators produced in any situation is tightly 93 
regulated and can be altered by a variety of mechanisms. In addition to varying amounts of precursor 94 
present in the cell, we and others have shown that PUFAs influence endometrial PG production by: (i) 95 
regulating PTGS expression [9-11]; (ii) altering the proportions of 1-, 2- and 3-series PGs produced [9] 96 
and (iii) changing the PGE:PGF ratios through altered expression of PG synthases [12]. PTGS1 and 97 
PTGS2 have similar actions but are encoded by different genes which are regulated differentially in a 98 
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cell-specific manner [13]. AA is the preferred substrate for both enzymes, so EPA metabolism to 3-series 99 
PGs is poor, and EPA also inhibits PTGS1 activity [14].  100 
 101 
Steroid synthesis 102 
 103 
PUFAs also have the ability to regulate steroid hormone production, again through a variety of both direct 104 
and indirect mechanisms. Steroids are derived from cholesterol as precursor and PUFAs can influence the 105 
function of transcription factors which regulate cholesterol metabolism [15]. For example, PUFAs can 106 
induce or suppress expression of the Liver X receptor, LXRα, which is a cholesterol-sensing transcription 107 
factor which plays a key role in lipid metabolism [16]. Steroid production is also influenced by PGs. For 108 
example, PGI2 is stimulatory to progesterone synthesis by the early stage corpus luteum [17], whereas 109 
PGF2α is the main luteolytic factor causing demise of the corpus luteum at the end of the oestrous cycle 110 
[18,19]. 111 
 In order for cholesterol to become available for steroid hormone synthesis, it must first traverse the 112 
outer mitochondrial membrane to gain access to the enzyme cytochrome P450cscc, which resides on the 113 
inner membrane. This is considered the rate limiting step in steroid biosynthesis and is controlled by 114 
steroidogenic acute regulatory protein (StAR) [20]. Both PUFAs and PUFA metabolites can 115 
stimulate/inhibit StAR expression and these actions on StAR are inevitably associated with either an 116 
increase or decrease in steroid output [21]. For example, inhibition of endogenous release of AA inhibited 117 
dibutyryl cyclic AMP (dbcAMP)-induced steroid synthesis as well as StAR promoter activity, StAR 118 
mRNA and StAR protein, whereas addition of exogenous AA  reversed all these effects [22].  119 
 With respect to reproductive physiology, a fish oil supplemented diet increased circulating 120 
oestrogen concentrations in pre- but not post- menopausal women [23]. Another recent observation was 121 
that fish oil altered oestradiol signalling pathways in human breast cancer cells to promote apoptosis at 122 
the expense of growth [24]. This change was probably mediated via the G protein coupled membrane 123 
receptor GPER1 rather than the classic oestradiol receptor, ERA. 124 
 There is also evidence for signalling in the opposite direction, with steroid hormones affecting 125 
PUFA metabolism. Female mammals have a greater ability to synthesize the LCPUFAs EPA and DHA 126 
from ALA than males [25]. During oestrous/menstrual cycles and pregnancy the reproductive tract is 127 
exposed to alternating periods of oestrogen and progesterone dominance. Oestrogen up-regulates the 128 
desaturases, so increasing the conversion of ALA and LA to LCPUFAs [26] to produce 129 
inflammatory/anti-inflammatory mediators. In contrast, progesterone inhibits uterine eicosanoid synthesis 130 
and stimulates and maintains production of PG dehydrogenase (PGDH) which inactivates PGs [27,28].  131 
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 132 
Transcription factor regulation 133 
 134 
PUFAs can alter the function of a number of other transcription factors. Amongst the most studied are 135 
PPARs, a subfamily of nuclear receptors with three known  subtypes α, β, and  γ, which are expressed in a 136 
tissue specific manner [29]. A variety of long-chain 18C and 20C unsaturated-, polyunsaturated-, and 137 
branched chain fatty acids and prostaglandins act as endogenous ligands for PPARs [30]. PPARs 138 
influence steroidogenesis as they can induce the expression of a variety of genes whose encoded proteins 139 
are involved in the biosynthesis and metabolism of cholesterol and fatty acids [31]. PPAR activation also 140 
inhibits NF-kB signalling to decrease cytokine production and these pathways may play important roles 141 
in regulating inflammation [32,33]. AA acts through PPARα to increase PTGS2 expression in bovine 142 
endometrium [11]. There is also evidence that fish oil supplementation can influence gene expression in 143 
bovine endometrium [33]. Nuclear receptor subfamily 1, group H, member 3 (NR1H3) is another 144 
transcription factor known to respond to PUFAs [34].   145 
 146 
Membrane properties 147 
 148 
PUFAs become incorporated into the plasma membranes of all cells and can influence several aspects of 149 
membrane physiology which are important in reproductive biology. The fluidity of the membrane is 150 
strongly influenced by the lipid component. This property in turn affects the ability of sperm to fuse with 151 
the egg at fertilization and it also affects the sensitivity of sperm and oocytes to chilling and freezing, 152 
important in assisted reproduction [35]. For example, in oocytes collected from ewes fed a diet 153 
supplemented with Ca-soap of fish oil for 13 weeks the proportion of LCPUFAs in cumulus cell 154 
phospholipids increased by 12.7% and this was associated with improved integrity and physical 155 
properties of oocyte membranes and better resistance to chilling [36].  156 
 Unsaturated fatty acids are also vulnerable to attack by reactive oxygen species (ROS) which can 157 
initiate a damaging lipid peroxidation cascade [6,38]. Membrane potentials and intracellular ionic 158 
concentrations are controlled by different types of ion channels. Free PUFAs can modulate the voltage-159 
dependence of voltage-gated channels. This has mainly been studied with respect to neuronal and cardiac 160 
cell activity [39] but is also important at fertilization [40]. 161 
Lipid rafts are localized regions in plasma membranes which are rich in cholesterol, sphingolipids 162 
and phospholipids. Specific proteins localize to these regions, including those involved in signal 163 
transduction pathways and T cell activation [41,42]. This partitioning promotes efficient signalling by 164 
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clustering of relevant proteins. When n-3 PUFAs, in particular DHA, become incorporated into 165 
membrane phospholipids they cause lipid raft regions to merge, with an associated depletion of 166 
cholesterol and sphingolipids and partitioning of some proteins away from the raft.  This can interfere 167 
with some cell-signalling pathways, for example T-cell activation and epidermal growth factor (EGF) 168 
receptor signalling [42]. This is one mechanism by which the n-3 LCPUFAs act as anti-inflammatory 169 
agents. We have found that in vitro treatment of uterine epithelial cells with GLA or AA reduces 170 
responsiveness to oxytocin (OT) challenge [43,44]. This may possibly involve altered response through 171 
the oxytocin receptor (OTR), although the underlying mechanism has not been investigated. 172 
 173 
Immune Function 174 
 175 
PUFAs derived from fish oil (EPA and DHA) are known to have anti-inflammatory properties [45]. As 176 
outlined above, their incorporation into cells of the immune system decreases the AA content and so 177 
reduces the production of pro-inflammatory (2-series) eicosanoids derived from AA. EPA instead gives 178 
rise to 3-series eicosanoid mediators that are less inflammatory, while both EPA and DHA are precursors 179 
for resolvins that are actively anti-inflammatory and inflammation resolving. n-3 PUFAs can also alter 180 
immune function via effects on phagocytosis, T-cell signalling and antigen presentation mediated through 181 
changes in both cell membrane composition and eicosanoid signalling as outlined above. An extensive 182 
review of studies in which humans received n-3 supplementation concluded that there was good evidence 183 
for inhibition of lymphocyte proliferation, although changes in cytokine production were inconsistent 184 
[46]. Positive local effects were detected in patients with on-going inflammatory conditions, often in the 185 
absence of changes in immune markers of inflammation in the peripheral circulation. Healthy controls did 186 
not, however, show the same responses. With respect to reproduction, susceptibility of the genital tract to 187 
infection is greater in the luteal than the follicular phase of the cycle [27,47]. Progesterone inhibits NFkB 188 
activity which regulates cytokine and chemokine production, reducing the influx of neutrophils and 189 
monocytes to the uterus [48]. Supplementation with n-3 PUFAs may synergize with this effect since they 190 
also down-regulate NF-kB activity [33].  191 
 192 
Problems of interpretation 193 
 194 
This brief overview of possible mechanisms of action for PUFAs on reproduction illustrates just how 195 
complex the system is. Before reviewing studies which have investigated the effects of PUFAs on female 196 
reproduction, it is pertinent to consider briefly possible reasons for the frequent inconsistencies in the 197 
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results reported. For in vivo work, it is initially hard to formulate a diet in which only one PUFA is 198 
increased or decreased, as available food sources contain mixtures of different PUFAs. Other aspects of 199 
the diet such as protein and energy content also need to be equalised between treatment groups. This is 200 
particularly hard to achieve in human populations, but is also challenging for farm livestock such as 201 
ruminants. Ruminant diets require a fodder component such as grass or silage, whose PUFA levels may 202 
differ considerably, and in which the absorption level is further influenced by rumen dehydrogenation. 203 
The extent of the biohydrogenation can, however, be reduced in supplementary feeds by the use of 204 
protected oils such as calcium soaps which bypass the rumen and release LCPUFA into the small 205 
intestine [49].  Pure oils can be used for in vitro experiments but these often fail to reflect the complex 206 
biology of the whole body. PUFAs obtained from the diet will be metabolised to various extents and 207 
taken up in a tissue-specific manner. The way any one cell will react depends on both the balance of 208 
different PUFAs and other lipids stored within it and the precise signals it receives from the periphery and 209 
surrounding cells. In particular the n-3 to n-6 ratio is likely to be important and there are clear dose 210 
responses for individual PUFAs which can change effects from stimulation to inhibition. Although 211 
dietary input is clearly able to alter cellular PUFA concentrations, these will also depend to some extent 212 
on the levels present in the body before the experiment started, which in turn will vary between different 213 
experiments and species used.  214 
 Another consideration is the physiological state of the animal, as this will affect lipid metabolism 215 
in general and thus the balance of storage and release. For example, animals in early lactation undergo 216 
lipolysis to support milk production, leading to elevated concentrations of circulating non esterified fatty 217 
acids [50]. Such animals are likely to show different response to those which are gaining weight. Finally 218 
there is another key problem relating to all work where the measured outcome is conception and this is 219 
the need for adequate numbers of animals in each group to provide sufficient statistical power. The effects 220 
of dietary PUFAs on fertility are unlikely to be major. For a monotocous species such as the cow, power 221 
calculations show that about 800 animals are needed to show a 5% difference in conception rate at 222 
P<0.05.  For polytocous species such as the pig around 40 sows should be sufficient to detect a 5% 223 
change in litter size. Much of the published work on fertility effects has therefore been underpowered. 224 
 225 
Evidence for actions 226 
 227 
Follicle development 228 
 229 
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A number of studies provide evidence that various LCPUFAs (both n-3 and n-6) can influence the growth 230 
and development of ovarian follicles, ovulation rate and the timing of ovulation. One consistent, although 231 
not universal, finding across a number of studies on both dairy and beef cattle was an increase in the 232 
numbers of antral follicles present on the ovaries [51-57]. In some dairy cow studies, there was also an 233 
increase in the size which the dominant follicle reached before ovulation [51,55,58-60]. Effects on 234 
follicular steroidogenesis have also been noted. High n-3 PUFAs increased the level of progesterone in 235 
the follicular fluid [61] which was mainly produced in the theca cells and was associated with an increase 236 
in StAR expression [62]. Higher circulating concentrations of oestradiol were present in the follicular 237 
phase in cows supplemented with ALA [57] and granulosa cells collected from follicles of n-6 PUFA 238 
supplemented cows showed increased steroid secretion in vitro [53]. In humans, higher baseline 239 
concentrations of oestradiol were found in women consuming more ALA in their diet [63], concentrations 240 
of n-3 LCPUFAs were positively associated with circulating oestradiol and progesterone [25] and fish oil 241 
supplementation increased both oestradiol and oestrone levels in pre- (but not post) menopausal women 242 
[23].   243 
The ovulation rate was not altered following dietary supplementation with saturated fatty acids or 244 
PUFAs (LA, AA, ALA, EPA and/or DHA) in superovulated cows [64,65], pigs  [66-68], or rats [69]. In 245 
other papers, however, EPA or fish oil was reported to decrease the number of ova released by rats [70] 246 
and mice [71], in which more oocytes became trapped in luteinized follicles, whereas both ALA and 247 
EPA+DHA increased the ovulation rate in rats [72]. Some experiments have examined possible effects of 248 
PUFAs on ovarian PG synthesis as this could alter the ability of follicles to ovulate, a process which is 249 
dependent on increased PGE production [73]. One difficulty with interpretation is that the PG assays used 250 
(which are mainly antibody binding assays) generally fail to differentiate 2-series from 3-series PGs as 251 
this can only be done reliably following separation by high performance liquid chromatography or 252 
gas/liquid chromatography-mass spectrometry systems. Feeding dairy cows with a high n-3 PUFA diet 253 
resulted in a lower level of PGE in the follicular fluid from large follicles [74]. Similarly feeding fish oil 254 
to mice deceased ovarian production of both PGF2 and PGE via reduced PTGS2 [71]. The work of 255 
Broughton and colleagues showed that DHA alone increased production of 3-series prostaglandin E and F 256 
in rat ovaries [69], EPA increased PGE and PGF [70] and ALA increased PGF but reduced PGE [72]. 257 
While there are inconsistencies, there is thus a trend across several species to suggest that the anti-258 
inflammatory properties of n-3 PUFAs can reduce follicular production of PGE2, so causing dominant 259 
follicles to grow larger and produce more steroid before ovulating. 260 
 261 
Uterine activity  262 
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 263 
Evening primrose and borage oil, which contain high concentrations of GLA, are promoted to the human 264 
population for their anti-inflammatory properties. This may be because they increase the synthesis of 1-265 
series rather than 2-series PGs [9,75]. It has been suggested that GLA containing oils increase uterine 266 
contractions [76], thus leading to induction of labour [77,78] but evidence to support this is lacking.  267 
 268 
Postpartum period  269 
 270 
Uterine involution after calving in cows is associated with an up-regulation of PGF production, 271 
commonly measured as a rise in the metabolite 15-keto-dihydro-PGF2 alpha (PGFM) in the circulation 272 
for about 3-4 weeks after calving [79]. This is part of a normal physiological response, although almost 273 
all dairy cows experience a uterine infection at this time [80] and such infections may prolong the period 274 
when PGFM is elevated [79]. Dietary PUFAs could potentially influence several aspects of reproductive 275 
function during the postpartum period: PG synthesis, the immune response to uterine infection and the 276 
timing of the first ovulation. In practice all these are inter-related.  277 
Several studies in cattle have investigated the effects of PUFA supplementation pre-partum on 278 
plasma PGFM concentrations after calving. In general this increased PGFM levels in both dairy [3,81] 279 
and beef [82,83] cows, whereas Mattos et al. [84] found that a fish oil supplement reduced PGFM. 280 
Supplementing with C18:2 n-6 decreased the incidence of uterine disease after calving and feeding a 281 
calcium salt rich in LA and trans-octadecenoic acid (LTFA) from 25 days prepartum to 80 days 282 
postpartum tended to decrease the incidence of puerperal metritis (15.1 vs. 8.8%) but had no effect on 283 
retained placenta or other aspects of uterine disease [81].  284 
Various fat supplements have led to a shorter interval to first ovulation postpartum in some studies. 285 
This was observed in cows fed calcium salts of long chain fatty acids (Ca-LCFA) [55,85]. Similarly cows 286 
fed either LA (linola) or ALA (flaxseed) supplementation exhibited shorter calving to first ovulation 287 
interval than those fed oleic acid (canola) (23.7 ± 3.2 d and 21.0 ± 3.1 d, vs. 34.7 ± 3.1 d respectively) 288 
[86]. Two studies found that transition cows supplemented with a rumen inert fatty acid mixture 289 
(Megalac®, composition: 47% palmitic acid (C16:0), 5% stearic acid (C18:0), 38% oleic acid (C18:1), 290 
9% LA, 1% ALA) ovulated sooner after calving than cows on a control or soybean supplemented diet 291 
[87,88]. Similarly, dairy cows on pasture which received a soybean oil by-product had an earlier first 292 
ovulation (26.7 vs. 42.4 day postpartum) [89]. A sunflower seed supplement increased the likelihood that 293 
the first dominant follicle to develop after calving would ovulate, but only in primiparous and not 294 
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multiparous cows [90]. Earlier ovulation after calving therefore seems to be a fairly consistent finding, 295 
but it is not currently clear if this is due to a specific PUFA effect or just the supply of extra energy.  296 
Fatty acid profiles of follicular fluid and oocytes 297 
Removal of the oocyte from the follicular environment in vitro initiates a spontaneous resumption of 298 
meiosis. In contrast, follicular fluid of the preovulatory follicles supports oocyte maturation in vivo [91]. 299 
Follicular fluid thus plays has a key regulatory role in oocyte development. PUFAs accumulate in 300 
follicular fluid via a concentration gradient reflecting serum ‎levels [92] and constitute the major portion 301 
of the fatty acid content of bovine follicular fluid. The most predominant fatty acid, contributing about a 302 
third of the total, is LA with important contributions from oleic, palmitic, stearic acids and ALA [93]. The 303 
relative contributions are influenced by follicle size, with more LA (18:2) in small follicles and ALA 304 
(18:3) in large follicles [93].  305 
The oocytes in turn take up PUFAs from the follicular fluid. In cattle, cumulus oocyte complexes 306 
(COCs) contain a greater proportion of saturated FA (45-87% of total FAs) compared to MUFAs (11-307 
34%) and PUFAs (2-21%) [94]. Palmitic, stearic and oleic acids were again the most prominent together 308 
with some LA and AA [95,96]. One study in cattle [97] found that dietary changes can alter the PUFA 309 
content of oocytes. In contrast, supplementation of dairy cows with Ca salt of FA increased the PUFA 310 
content of plasma and follicular fluid but not the COCs [94]. The fatty acid composition of lipids in the 311 
oocytes was also found to vary according to many factors including species [96], quality of the oocyte 312 
[98] and season [99]. 313 
 314 
Oocyte quality and embryo development 315 
Many studies, mainly conducted in cattle, have investigated the effects of PUFAs on oocyte and embryo 316 
development. This is achieved either by feeding the dam differing diets and then flushing oocytes from 317 
antral follicles, or using abattoir derived oocytes followed by maturation in media of differing PUFA 318 
composition. Dietary supplementation with sunflower or other vegetable oils, linseed oil, fish oil or oleic, 319 
palmitic or stearic acids did not affect oocyte quality, fertilisation rate or embryo quality in dairy cows 320 
[58] or beef heifers [65], although another study reported a lower blastomere number in embryos derived 321 
from cows fed saturated fats [64]. In contrast, high fat supplementation of lactating dairy cows with 322 
Megalac® significantly improved blastocyst production and also improved the quality of the blastocysts 323 
produced in terms of increased total, inner cell mass and trophectoderm cell numbers [100]. Moreover, 324 
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feeding more unsaturated fatty acids in the form of Ca-LTFA (rich in LA) tended to increase the 325 
fertilisation rate, significantly increased the proportion of excellent and good quality embryos, decreased 326 
degenerated embryos and resulted in greater numbers of blastomeres compared to embryos from cows fed 327 
Ca salt of palm oil (rich in palmitic and oleic acids) [101]. For COCs collected from cows fed 328 
encapsulated flaxseed or sunflower oil, diet had no effect on the maturation rate; flaxseed however 329 
resulted in a higher cleavage rate compared to the control cows receiving no supplemental fat [97]. In 330 
complete contrast, feeding flaxseed to dairy cows decreased the fertilisation rate, percentage of grade 1 331 
and 2 embryos, and increased the percentage of degenerated embryos compared with Ca salts of palm oil 332 
[102].  333 
Turning to other mammalian species, fish oil supplementation to sheep improved oocyte yield and 334 
quality [103]. Feeding ewes fish oil or n-6 PUFA enriched diets did not affect embryo size or number 335 
following superovulation but the n-6 diet reduced development to blastocysts [61]. In contrast, a later 336 
study from the same group found that both the n-3 and n-6 diets increased blastocyst yield but these were 337 
of lower quality [62]. In pigs, n-3 supplementation did not alter ovulation rate or number and size of 338 
embryos [67,68]. Experiments on mice have also produced conflicting reports. Fish oil had little effect on 339 
oocyte quality and blastocyst development in one study [71], but altered mitochondrial distribution in 340 
oocytes, increased production of ROS and decreased embryo development to blastocysts in another [104]. 341 
Also in mice, conjugated linoleic acid (CLA) reduced the fertilization and blastocyst development rate but 342 
had no effect on litter size or ovulation rate [105]. In women undergoing a fertility treatment of IVF/ICSI, 343 
a high n-3 intake based on assessment of preconception diet improved embryo morphology, but the n-6 344 
content of the diet had no effect [63]. Another large scale study of over 18,000 married, subfertile women 345 
trying to establish a pregnancy reported that diets with high contents of trans unsaturated fats were at 346 
increased risk of ovulatory infertility but no associations were found with intakes of total, n-6 or n-3 347 
PUFAs [106].  348 
Using the in vitro approach, we have shown that n-3 ALA supplementation (50 µM) during 349 
maturation induced molecular and biochemical changes leading to improved bovine oocyte maturation 350 
and subsequent early embryo development [107], whereas  supplementation with n-6 LA (100 µM) was 351 
detrimental [108]. Similarly, Hochi et al. [109] reported that embryos cultured in the presence of LA had 352 
reduced development to the morula and blastocyst stages compared with embryos cultured in LA free 353 
media. Carro et al. [110] found that low doses of LA (9 and 43 µM) were beneficial whereas they agreed 354 
that 100 µM LA was harmful. Al Darwich et al. [111] concluded that supplementation with CLA or DHA 355 
during bovine IVF both reduced embryo development but ALA had a minor benefit. This was supported 356 
by work on IVF in goats where 50 µM ALA increased maturation and cleavage rates and blastocyst 357 
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formation [112]. Van Hoeck et al. [113] changed the order of diets fed to heifers then used serum 358 
collected from these animals to supplement in vitro bovine zygote development. The serum from the 359 
animals fed a diet high in saturated fat (C16:0) reduced blastocyst yield compared to controls, whereas the 360 
unsaturated fat diet (ALA) either reduced or improved embryo production depending on whether it was 361 
fed after or before the saturated fat diet.  362 
Based on the evidence to date it is therefore hard to make a convincing case that any particular 363 
PUFA supplemented to the diet before breeding will consistently improve embryo yield or quality. It is 364 
however possible that, where oocytes have been collected for IVF, the use of the same culture medium for 365 
all oocytes irrespective of the original diet may have masked any treatment effects. The in vitro 366 
supplementation effects are more consistent in showing a generally harmful effect of LA and beneficial 367 
effect of ALA, although the results are dose-dependent. 368 
A number of mechanisms have been suggested whereby PUFAs may influence oocyte quality. 369 
Firstly, triglycerides are the major component of the lipid content of the oocyte and act as an important 370 
energy reservoir [114,115]. Inhibition of fatty acid metabolism and β-oxidation during bovine oocyte 371 
maturation resulted in reduced development to blastocysts [116]. Dietary PUFAs could potentially alter 372 
the exogenous fatty acids available as an energy supply. Carro et al. [110] examined the uptake and 373 
nuclear status of bovine embryos matured in vitro with LA. All doses increased triacylglycerol 374 
accumulation in the cytoplasm. Low doses (9 and 43 µM) had no effect on the nucleus but the highest 375 
dose (100 µM) inhibited germinal vesicle breakdown (GVB), so a much higher proportion of oocytes 376 
arrested at the germinal state.  Homa and Brown [93] also found that 50 µM LA inhibited GVB. This may 377 
be because LA influenced mitochondrial activity and increased ROS concentrations in the oocytes [117]. 378 
ALA supplementation to oocyte maturation media increased intracellular cAMP concentration and 379 
increased phosphorylation of MAPK1 and MAPK3 and AKT during oocyte maturation in cattle [103], 380 
while LA resulted in the opposite effects [108]. Both cAMP and phosphorylation of MAPK in cumulus 381 
cells are downstream to G-protein coupled receptors, mainly gonadotrophin, EGF and prostaglandin 382 
receptors, suggesting that PUFAs can differentially alter membrane receptor functions in the COCs. 383 
Another possible action is via eicosanoid signalling. The bi-directional cross talk between the 384 
oocyte and surrounding cumulus cells is crucial for oocyte development. PGE2 is an important mediator 385 
of both oocyte maturation and cumulus expansion [118-121]. LA and ALA supplementation increased 386 
PGE2 production by bovine COCs during maturation. LA, but not ALA, also increased PGF2α levels to a 387 
lesser extent resulting in an overall increase in the PGE:PGF ratio in both treatments. The LA treatment 388 
resulted in production of extreme levels of PGs (≥ 20 times) compared to ALA, which may have 389 
contributed to the reduced maturation rate in LA-treated COCs [107,108]. 390 
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 391 
Luteal development 392 
 393 
After ovulation, the timing of the progesterone rise in the early luteal phase of dairy cows influences the 394 
likelihood of successful conception, with less evidence to support a major role for the mid cycle 395 
progesterone concentration [122]. Most studies have not found a change in luteal progesterone levels 396 
following various types of PUFA supplementation [56,59,123,124]. In one study, however, flaxseed 397 
supplementation resulted in higher progesterone levels in the late luteal phase [125] whereas another 398 
found a reduction in plasma progesterone associated with feeding either LA or ALA supplements to dairy 399 
cows [57].  400 
 401 
Luteolysis 402 
 403 
As in follicular fluid, dietary changes which alter circulating PUFA concentrations are also reflected in 404 
the endometrium [65,126-128]. It has been suggested that n-3 PUFA supplementation may suppress 405 
endometrial luteolytic PGF2α production and that this in turn may be beneficial for embryo survival, 406 
particularly in cattle [3]. One potential problem is that uterine PGF2α production is up-regulated in normal 407 
early pregnancy [129] with IFNτ treatment of bovine endometrial explants increasing both PGE2 and 408 
PGF2α output [130]. The topic was recently revisited by Ullbrich et al. [131], who concluded that up-409 
regulation of PG synthesis in early pregnancy (PGI2, PGE2 and PGF2α) was a key component of the bi-410 
directional signalling between the endometrium and the embryo. When ALA was fed to non-pregnant 411 
sheep the length of the luteal phase was indeed slightly prolonged, but only by about 1 day [132]. 412 
Similarly, Zachut et al. [97] found that dairy cows fed a high n-3 PUFA diet exhibited longer intervals 413 
from being given a PGF2α injection to manifestation of oestrus behaviour, which delayed the beginning of 414 
the subsequent luteal phase. This group of animals also showed a longer duration of their pre-ovulatory 415 
oestradiol surge [74].  416 
With respect to the effects on luteolysis, investigators have not measured the release pattern of the 417 
PGF metabolite PGFM in the blood during normal luteal regression as this requires taking serial blood 418 
samples over a number of days to determine the pattern of pulsatile release. An easier option is therefore 419 
to measure OT stimulated PGFM release. The problem with this approach is that the response is crucially 420 
dependent on how many OTR are present in the endometrium at the time of treatment. The OTR normally 421 
up-regulate on about day 17 of the bovine oestrous cycle [19], but in practice multiparous cows have quite 422 
variable cycle lengths (around 19-24 days). Some workers have primed cows with oestrogen, which 423 
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artificially increases the OTR population. To gain an accurate picture, the test should therefore be 424 
repeated on more than one day of a natural cycle and progesterone profiles and baseline PGFM values are 425 
required to confirm exactly when in the cycle the tests are performed. Using this approach, Robinson et 426 
al. [57] found that n-6 PUFA supplementation increased the PGFM response to OT on day 17 but not on 427 
days 15 or 16.  In a study of beef heifers, increasing n-3 PUFA concentrations through higher fish oil 428 
supplementation produced a clear dose response rise in PGFM on day 15 but this was no longer seen on 429 
day 16 of the cycle [65].  430 
Gulliver et al. [133] recently reviewed 10 studies where cows received PUFA supplements 431 
followed by OT challenge during the oestrous cycle to measure PGFM response. Of these, three studies 432 
reported no effect and in three the results differed according to either the progesterone profile or the day 433 
of the cycle. Petit et al. [134] found that n-3 PUFAs increased the baseline for PGFM but reduced the 434 
response to OT. There were two reports that PGFM release was lower with n-3 supplementation (fishmeal 435 
or linseed) [124,135] and two that it was higher after sunflower seeds or Megalac (both high in n-6) 436 
[136,137]. This clearly indicates the extreme inconsistency of the responses to n-3 in the diet although 437 
there is more agreement for a rise in PGFM after n-6. Gulliver et al. [133] commented on difficulties of 438 
interpretation given the variety of supplements used and the lack of FA analysis in the diet and/or plasma 439 
in several studies.  440 
One study fed beef heifers a fish oil supplemented diet for 45 days then collected tissues on day 17 441 
of a synchronised oestrous cycle. The high n-3 diet altered gene endometrial expression of a number of 442 
transcription factors, PG and steroid synthetic enzymes and immune regulators [34,127]. Similarly, a fish 443 
oil diet altered expression of steroid receptors and PTGS2 in bovine endometrium, also on day 17 [137]. 444 
The significance of these changes to fertility remains uncertain. 445 
 446 
Embryo development and pregnancy rate 447 
 448 
As PUFA supplemented diets are fed with the intention of improving pregnancy rate, this is a better 449 
measure of success than PGFM responses to OT. Much larger numbers of animals are, however, required 450 
to achieve statistical significance, so many studies have been under powered. Staples et al. [49] 451 
summarized work investigating the effect of fat supplementation on reproductive performance of lactating 452 
dairy cows, and stated that eleven out of twenty studies have shown an average of 17% improvement in 453 
conception or pregnancy rates. This was achieved using different types of fats: rumen inert fat, fish meal, 454 
tallow or prilled fat. In general, pregnancy rates were higher and/or pregnancy losses lower with a high n-455 
3 (ALA or fish oil) supplement compared with high n-6 or saturated fat [3,49,59,65,123,125,138]. On the 456 
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other hand, n-6 supplements may reduce pregnancy rates in cattle [139]. Yet other studies have not found 457 
any effect of either LA or ALA supplements on pregnancy rates [57,83,125,140-142]. More recently, 458 
Lopes et al. [139,143] fed rumen inert PUFA (Megalac-E, 31% LA, 2.7% ALA) to large numbers of Bos 459 
indicus cattle in two series of experiments to test the effect at different time periods in the 4 weeks after 460 
AI or embryo transfer in comparison with saturated fat or kaolin (control) supplements. The PUFA 461 
supplement had a consistent positive effect of around 10% on pregnancy rate which was better when fed 462 
over a longer time period, particularly after day 14 of gestation. Thus it can generally be concluded that 463 
fat supplemented diets can positively improve pregnancy rates in dairy cows when compared to cows 464 
receiving isoenergetic diets with no fat supplement and that ALA-rich diets tend to be more efficient 465 
when compared to diets rich in LA. The results are, however, inconsistent. 466 
 Whilst the majority of studies have focussed on cattle, Chavarro et al. [106] set a food 467 
questionnaire to over 18,000 subfertile women trying to establish a pregnancy. They concluded that 468 
intakes of total, n-3 or n-6 PUFAs were not associated with the chances of conception in women with 469 
ovulatory infertility. Another study fed an evening primrose oil supplement (high in GLA) to blue foxes. 470 
Both the conception rate and the abortion rate increased, so there was no overall effect on the number of 471 
females producing litters [144]. Other workers have examined the effects of dietary PUFAs on the 472 
subsequent pregnancy in pigs. The most common response has been a small increase in litter size. Palmer 473 
et al. [145] fed mated gilts fish meal and increased litter size by 0.5 to 1.2 piglets (although other 474 
components of the fish meal may also have been beneficial). Two other studies similarly increased litter 475 
size by 0.8 and 1.0 piglets respectively when sows received a protected fish oil before mating [146,147]. 476 
A subsequent experiment found a similar trend in gilts for survival to Day 25 of gestation but only when 477 
the supplementary feeding was continued during early pregnancy [148]. As ovulation rate was not 478 
increased, the most likely influence was on embryo survival, a similar situation to the cow.  479 
 480 
Transgenic experiments 481 
 482 
Some experiments in mice which have used a transgenic approach to manipulating endogenous PUFA 483 
production have also examined fertility. Pohlmeier et al. [149] increased the expression of Fat-1 (omega3 484 
fatty acid desaturase), leading to higher synthesis of n-3 PUFA.  This led to a decreased litter size from 485 
7.2 to only 2.7 pups. The ovulation and fertilization rates were normal but there were fewer pre-486 
implantation embryos and a higher rate of post implantation absorption. By transferring embryos between 487 
transgenic and wild type mice, the authors were able to show that the fault was in the oocyte regardless of 488 
the genotype of the female reproductive tract. A study by Stoffel et al. [150] knocked out the enzyme 489 
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FADS2 (∆6 desaturase) thus stopping the onwards conversion of LA and ALA, so mice could not produce 490 
their own LCPUFAs. Both male and female mice were infertile. The structure of the testes and ovaries 491 
were very abnormal, with breakdown of the blood-testis barrier and disrupted folliculogenesis. 492 
Prostaglandin levels in these animals were very low, although they did make some as they acquired small 493 
amounts of LCPUFAs directly from the diet. It was possible to restore fertility by supplementing the diet 494 
with either AA or DHA/EPA. Both these studies therefore support the need for “normal” PUFA levels to 495 
achieve development of fertile eggs within the ovary.  496 
 497 
Conclusions 498 
 499 
PUFAs have multiple actions within the body which can impact on fertility. Most evidence for specific 500 
functions is based on in vitro work and this often fails to translate into consistent in vivo effects. There are 501 
many potential reasons for this but a pervading difficulty is to change concentrations of individual PUFAs 502 
and the ratios between them in particular tissues in a predictable manner. While tissue contents do reflect 503 
dietary intake, suitable diets which alter the levels to a sufficient extent are hard to devise and variations 504 
in metabolic status and health between individual animals will always be important. There is some 505 
evidence that n-3 PUFAs in particular can benefit some aspects of fertility, but this requires validation in 506 
larger studies to ensure that the supposed benefits are of sufficient size and consistency to be cost 507 
effective in practice.  508 
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Figure Legend 
 
Figure 1.  Diagram showing the metabolic pathways for n-3 and n-6 PUFA metabolism. These lead to the 
production of lipid mediators with pro-inflammatory, anti-inflammatory and pro-resolution effects: LX, 
lipoxin; PG, prostaglandin; RvE, resolvin. Enzymes are shown in italics: LOX, lipoxygenase; PTGS, 
prostaglandin endoperoxide synthase. 
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